Telehealth providers in Delaware

Verified telehealth providers serving Delaware

Telehealth prescribing rules in Delaware

Delaware repealed its older physician telemedicine section (24 Del. C. 1769D) effective July 1, 2021 and moved telehealth rules for all professions into Title 24, chapter 60. Section 6001 defines telemedicine to include secure video conferencing and store and forward transfer, which may be synchronous or asynchronous. Section 6003 requires a health-care provider-patient relationship before telehealth care; the relationship may be established in person or through telehealth but must include verification of the patient's identity and location and disclosure of the provider's identity and credentials, and without a proper relationship a provider may not issue a prescription solely in response to an internet questionnaire, internet consult, or telephone consult. The Division of Professional Regulation also issues interstate telehealth registrations that let physicians and physician assistants licensed in good standing in another state treat Delaware patients by telehealth without a full Delaware license. Section 6003(b) answers the asynchronous question directly: telehealth services may be synchronous or asynchronous using store-and-forward technology, and telehealth may be used to establish the provider-patient relationship if the provider determines the provider can meet the same standard of care as an in-person visit. Section 6004(a) adds that before diagnosis and treatment the provider must do at least one of the following: an in-person exam, having another Delaware-licensed provider present with the patient, making the diagnosis using audio or visual communication, or meeting professional society guidelines for establishing a relationship in evidence-based telemedicine practice. An asynchronous first prescription is therefore allowed when those conditions are met, but not one issued solely from an internet questionnaire without a proper relationship. [2] [3] [4]

Compounded GLP-1 access in Delaware

Delaware patients using an out-of-state telehealth GLP-1 program should confirm the prescriber is Delaware-licensed or holds an interstate telehealth registration, and that the pharmacy holds a Delaware nonresident pharmacy license. [4] [6] [10]

Research use only sellers in Delaware

Only Delaware-licensed pharmacies and licensed nonresident pharmacies may dispense prescription drugs to Delaware patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law, are not dispensed by a pharmacist, and fall outside Delaware's pharmacy licensing system. Delaware's own food and drug law (16 Del. C. chapter 33, Pure Food and Drugs) prohibits manufacturing or selling an adulterated or misbranded drug (section 3302) but has no separate new-drug approval provision, so the prohibition on selling unapproved new drugs comes from federal law. [6] [8] [11]